Featured Research

from universities, journals, and other organizations

Sandia Demonstrates Device For Preventing Battlefield Friendly Fire

Date:
October 28, 2005
Source:
Sandia National Laboratories
Summary:
Sandia, General Atomics Aeronautical Systems, and Sierra Monolithics demonstrated the Athena Radar-Responsive Tag during a recent military exercise in the U.K. Aircraft on bombing runs used their radar systems to spot unique signals from Athena tags carried on vehicles belonging to friendly forces.

Athena can be used to identify both U.S. and coalition forces during combat to avoid friendly fire.
Credit: Image courtesy of Sandia National Laboratories

ALBUQUERQUE, N.M. - Sandia National Laboratories, along with partners General Atomics Aeronautical Systems, Inc. and Sierra Monolithics Inc., demonstrated the Athena Radar-Responsive Tag during Exercise "Urgent Quest" in the United Kingdom (Salisbury Plains Training Area) Sept. 19 through Oct. 9, 2005.

Athena was developed with sponsorship from the U.S. Army CERDEC I2WD Division and the U.S. Air Force Air Warfare Battlelab.

Urgent Quest is a Military Utility Assessment, associated with the Coalition Combat Identification (CCID) Advanced Concept Technology Demonstration (ACTD), organized to demonstrate the effectiveness of new technologies in preventing friendly fire, or fratricide.

The final report for the exercise will be released in March 2006.

During the demonstration, Athena tags were placed on military vehicles participating in the exercises. The device, tracked via aircraft radar, can be used to identify both U.S. and coalition forces during combat to avoid fratricide. During war, fratricide is the act of killing one's own soldiers.

Aircraft on bombing runs used their on-board radar systems to ensure there were no friendly troops in their sights. If an Athena-tagged vehicle was present, a unique identifier appeared on the pilot's screen alerting him to a friendly force in his target area, thereby avoiding a potential friendly fire incident.

In preparation for Exercise Urgent Quest, the Athena tag has been demonstrated with several U.S. and European aircraft. In addition to combat identification, the tag can be used for blue force tracking, a similar but not identical mission.

Sandia Project administrator Darick Lewis says the exercises were intended to evaluate the effectiveness of various technologies in preventing friendly fire.

"Ideally, worthy candidate technologies can be transitioned into final development programs and produced for warfighter use," he says. "Athena is effective because it utilizes a fighter aircraft's existing radar for detection. It is simple, rugged, small and inexpensive to integrate."

###

General Atomics Aeronautical Systems, Inc. (GA-ASI), an affiliate of privately held General Atomics, provides comprehensive solutions for military and commercial applications worldwide. GA-ASI is committed to providing immediately deployable transformational technology for military operations and weapons systems, as well as civil missions. For more information, visit www.uav.com.

Sierra Monolithics Inc. is a leading supplier of high frequency mixed signal ICs and modules for the wireless and telecommunication industries. The company is privately held. For more information, visit www.monolithics.com.

Sandia is a multiprogram laboratory operated by Sandia Corporation, a Lockheed Martin company, for the U.S. Department of Energy's National Nuclear Security Administration. With main facilities in Albuquerque, N.M., and Livermore, Calif., Sandia has major R&D responsibilities in national security, energy and environmental technologies, and economic competitiveness.



Story Source:

The above story is based on materials provided by Sandia National Laboratories. Note: Materials may be edited for content and length.


Cite This Page:

Sandia National Laboratories. "Sandia Demonstrates Device For Preventing Battlefield Friendly Fire." ScienceDaily. ScienceDaily, 28 October 2005. <www.sciencedaily.com/releases/2005/10/051028104844.htm>.
Sandia National Laboratories. (2005, October 28). Sandia Demonstrates Device For Preventing Battlefield Friendly Fire. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2005/10/051028104844.htm
Sandia National Laboratories. "Sandia Demonstrates Device For Preventing Battlefield Friendly Fire." ScienceDaily. www.sciencedaily.com/releases/2005/10/051028104844.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins